Predictive factors of adverse outcomes of atrial fibrillation in elderly patients: Results of the National Tunisian Registry of Atrial Fibrillation (NATURE-AF)
##plugins.themes.academic_pro.article.main##
Abstract
Introduction: Atrial fibrillation (AF) is the most frequent sustained cardiac arrhythmia. Data related to its clinical characteristics, management, and predictive factors of poor outcomes in elderly in Tunisia remain scarce. We aimed to evaluate the predictive factors of adverse outcomes in the elderly at 12 months follow-up among AF patients in Tunisia including thromboembolic (TE) events, hemorrhagic events, and all-cause death.
Methods: We conducted a national, prospective, and analytic multicentric study based on NATURE-AF with a 12-month follow-up period between March 1, 2017, and May 31, 2017. We evaluated the predictive factors of adverse outcomes of AF in the elderly (≥ 75 years old).
Results: We included 915 patients with AF. We studied the elderly who represented 24% of the population. Females represented 52% of the elderly. Hypertension was present in 57% of the elderly, diabetes mellitus in 22.4%, dyslipidemia in 16%, obesity in 75.8%, chronic kidney disease in 22.8% and smoking in 13.2%. Prior TE accidents and hemorrhagic accidents happened in 12.8% and 3.7% respectively. The mean CHA2DS2-VASc score was 3.92±1.28. Vitamin-K-Antagonist was used in 59.8%. The mean TTR was 47.53±26.78. The rate control strategy was adopted in 68% of patients and beta-blockers were used in 37.9%. Hospitalization during the follow-up for adverse causes occurred in 13.4%. Adverse outcomes occurred in 19.6% including 3.2% TE events, 5% hemorrhagic events, and 11.4% deaths. After multivariate analyses, prior TE accidents (ORa=3.218; p=0.025; 95%CI [1.157-8.946]) and hospitalization during the follow-up (ORa=6.489; p=0.002; 95%CI [2.035-20.697]) were independent prognostic ...(abstract truncated at 250 words).
Keywords:
Atrial fibrillation, Elderly, Comorbidities, Management, Outcome, Tunisia, North Africa##plugins.themes.academic_pro.article.details##
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
- Joglar JA, Chung MK, Armbruster AL, Benjamin EJ, Chyou JY, Cronin EM, et al. 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Journal of the American College of Cardiology. 2024 Jan 2;83(1):109–279.
- As G, Em H, Ka P, Y C, Le H, Jv S, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA [Internet]. 2001 Sep 5 [cited 2024 Jan 23];285(18). Available from: https://pubmed.ncbi.nlm.nih.gov/11343485/
- Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke. 1991 Aug;22(8):983–8.
- Miyasaka Y, Barnes ME, Bailey KR, Cha SS, Gersh BJ, Seward JB, et al. Mortality Trends in Patients Diagnosed With First Atrial Fibrillation: A 21-Year Community-Based Study. Journal of the American College of Cardiology. 2007 Mar 6;49(9):986–92.
- Vesin C, Protogerou AD, Lieber A, Safar H, Iaria P, Ducimetière P, et al. Predictive factors for all-cause mortality in the hospitalized elderly subject: The importance of arrhythmia. Atherosclerosis. 2009 Dec 1;207(2):507–13.
- Béjot Y, Salem DB, Osseby GV, Couvreur G, Durier J, Marie C, et al. Epidemiology of ischemic stroke from atrial fibrillation in Dijon, France, from 1985 to 2006. Neurology. 2009 Jan 27;72(4):346–53.
- Ouali S, Ben Halima A, Chabrak S, Chettaoui R, Ben Halima M, Haggui A, et al. Epidemiological characteristics, management, and outcomes of atrial fibrillation in TUNISIA: Results from the National Tunisian Registry of Atrial Fibrillation (NATURE-AF). Clin Cardiol. 2021 Apr;44(4):501–10.
- Tsuda T, Hayashi K, Kato T, Usuda K, Kusayama T, Nomura A, et al. Clinical Characteristics, Outcomes, and Risk Factors for Adverse Events in Elderly and Non-Elderly Japanese Patients With Non-Valvular Atrial Fibrillation ― Competing Risk Analysis From the Hokuriku-Plus AF Registry ―. Circ Rep. 4(7):298–307.
- Oba K, Shinjo T, Tamashiro M, Matsuoka M, Arasaki O, Arima H, et al. Cause of Death and Associated Factors in Elderly Patients With Atrial Fibrillation - Long-Term Retrospective Study. Circ Rep. 2020 Aug 29;2(9):490–8.
- Marijon E, Le Heuzey JY, Connolly S, Yang S, Pogue J, Brueckmann M, et al. Causes of death and influencing factors in patients with atrial fibrillation: a competing-risk analysis from the randomized evaluation of long-term anticoagulant therapy study. Circulation. 2013 Nov 12;128(20):2192–201.
- 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS) | European Heart Journal | Oxford Academic [Internet]. [cited 2022 Oct 2]. Available from: https://academic.oup.com/eurheartj/article/42/5/373/5899003?login=false
- 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS) | European Heart Journal | Oxford Academic [Internet]. [cited 2024 Nov 23]. Available from: https://academic.oup.com/eurheartj/article/45/36/3314/7738779?login=false
- Liao JN, Chao TF, Chen SA. How do aging and comorbidities impact risk of ischemic stroke in patients with atrial fibrillation. Trends in Cardiovascular Medicine. 2019 Oct;29(7):386–91.
- Yamashita T, Suzuki S, Inoue H, Akao M, Atarashi H, Ikeda T, et al. Two-year outcomes of more than 30 000 elderly patients with atrial fibrillation: results from the All Nippon AF In the Elderly (ANAFIE) Registry. Eur Heart J Qual Care Clin Outcomes. 2022 Mar 2;8(2):202–13.